1103P 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials

Autor: Bongiovanni, A., Nicolini, S., Foca, F., Sansovini, M., Grassi, I., Liverani, C., Riva, N., Fausti, V., Mercatali, L., De Vita, A., Fabbri, L., Signoretti, M., Pacilio, C.A., Paganelli, G., Severi, S., Ibrahim, T., Tartaglia, A.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S912-S912
Databáze: ScienceDirect